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Stress echocardiography with dobutamine infusion for detection
or coronary artery disease is a potential alternative to exercise
stress testing with some theoretic advantages . Fifty patients who
were not receiving cardioactive medication were prospectively
studied with two-dimensional echocardiography and 12-lead elee-
trocardlography (ECG) during incremental dobutamine infusion
(5, 10, 15 and 20 gtgneg body weight per min, each dose for 8 min)
.
Images were analyzed by using an 11-segment tell ventrieular
model. All patients underwent correlative exercise
FCC and
coronary angfography, which revealed normal coronary arteries
in 14 and significant disease (0r70% diameter intends) in 36 .
Peak rate-pressure product during dobutamine infusion was
18,845 t 4,156 versus 23,740 t 6,158 mm Hg/min on exercise
(p < 0.01). Interobserver concordance for wall motion analysis
was good (kappa coefficient = 0 .77). The use of baseline (n = 14)
or reversible (n = 24) regional asynergy to define an abnormal
dobutamine echocardiogram resulted in a sensitivity fm detecting
coronary artery disease of 78% and a specificity of 93% . Corre-
Exercise electrocardiography is of established value in the
diagnosis and evaluation of patients with coronary artery
disease and also provides important prognostic information .
The two-dimensional echotardiographic equivalent of ST
segment depression on the electrocardiogram (ECG) as a
marker of myocardial ischetnia is a transient regional wall
motion abnormality (1 .2) .
This forms the basis of exercise
echocardiography, which has been widely reported and is
gaining increasing clinical acceptance (3) . However, some
patients are unable to exercise because of coexisting periph-
eral vascular, orthopedic or neurologic disease . whereas
others are poorly motivated to achieve a work load sufficient
to make the test interpretable . Several alternative methods
of provoking myocardial ischemia have therefore been eval-
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spooning data for the dobutamine ECC were 47% and 71% and
for the exercise ECG were 72% and 71%, respectively . The
devel6pment of new mltral regurgitation on Doppler color Itow
imaging in = 4) improved sensitivity to 81% without toss of
specificity .
Ioducible asynergy m new mittal regurgitation was observed
in 6150%) of 12 patients with single ., 6 (60%) of
to with doabk-
and 12 (86%) of 14 with tripe-vessel disease . The site of transient
asynergy presided additional
localizing information
. Exercise
duration and time to
diagnostic ST segment shift were shorter to
patients with coronary- artery disease with versus those without
echotardiographic evidence of ischemla (both p < 0
.05). Side
effects during dobutamine infusion were mild and short-lived .
Dobutamine stress echocardiography is well tolerated, is useful
for detection and assessment of coronary artery disease and is
applicable to patients unable to exercise .
Q Am Colt Card e! 1992;19c1203-11)
tinted, including atrial pacing (4) and pharmacologic stress
(5-10), but no consensus on the best technique has emerged .
Dobutamine is a predominant beta,-receptor agonist with
lesser effects on beta, and alpha, cardiovascular adrenocep .
toms III) . It has relative inotropic selectivity but can also
substantially increase heart rate, systemic blood pressure
and cardiac output, especially at higher infusion rates (12).
Experimental studies in open chest dogs with a critical
coronary stenosis have found that dobutamine is able to
induce echocardiographically detectable myocardial isch-
emia (13,14) more effectively than can dipyridamole (13) or
dopamine
(15).
Dobutamine stress has been evaluated in
combination with the 12-lead ECG (16),
thallium scintigra-
phy (17), radionuclide ventriculography (18) amt two-
dimensional echocardiography (6-10) in patients with coro-
nary artery disease, with encouraging results
(19) . Stress
echocardiography with dobutamine has the added advantage
of being technically easier than exercise echocardiography
.
with a shorter learning curve for the operator .
T,he purpose of this prospective study was therefore to
compare the diagnostic accuracy of dobutamine stress echo-
cardiography in the detection of coronary artery disease with
that of the dobutamine ECG and the exercise ECG and to
assess the safety, side effect profile and patient acceptability
of this approach.
3735-10971921s5 .00
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Methods
Study patients (Table 1)
. Between June 1989 and August
1990 we screened 54 patients referred for coronary angiog-
raphy for suspected coronary artery disease who satisfied
the study enrollment criteria . Patients with cardiac failure .
unstable angina, congenital or valvular heart disease, cardio-
myopathy, uncontrolled systemic hypertension or myocar-
dial infarction within the preceding month were excluded
.
Those with bundle branch block
. ?1 mm ST segment
deviation from the isoelectric line on the baseline ECG or a
previous history of significant cardiac arrhythmia were also
considered unsuitable . We did not proceed to stress echo-
cardiography in four patients who had poor endocardial
definition on transthoracic imaging at baseline
.
The remaining 50 patients (44 men and 6 women aged 54
z 9 years [range 28 to 691) underwent dobutamine stress
echocardiography, exercise testing and angiographic evalu-
ation in random order (Table 1) . All were in sinus rhythm
and none had severely impaired left ventricular function
.
Coronary arteriography revealed normal coronary arteries in
14 and single-, double- and triple-vessel disease in 12, 10 and
14 patients, respectively . Thirteen patients with coronary
artery disease had a definite history of previous myocardial
infarction (postinfarction time >1 year in nine and 3 to 12
months in four) . Patients continued taking short-acting ni-
trates as necessary, but other antianginal treatment was
withheld for 4 half-lives before both dobutamine and exer-
cise stress tests . The study protocol was approved by the
hospital ethics committee on human research . All patients
gave informed consent .
Dobutamine stress echocardiography . Baseline hemody-
namie . ECG and echocardiographic data were initially col-
lected, and the optimal transducer locations were marked on
the patient's chest . Under continuous ECG monitoring,
dobulamine was infused into a peripheral vein at an incre-
mental regimen of 5, 10, 15 and 20 ug/kg body weight per
min, each dose for 8 min. End points of the study included a
new wall motion abnormality, diagnostic ST segment shift .
significant symptoms or arrhythmia. a target heart rate (85%
of 220 beats/min minus age in years) or completion of the
protocol . A systolic blood pressure of 220 mm Hg or a
decrease rt30 mm Hg or to a value < 100 mm Hg were also
indications for test termination . Intravenous propranolol
(I mg) and atropine (1 .2 mg) were available to treat adverse
events. A 12-lead ECG was taken each minute with pediatric
size precordial electrodes to maximize the chest area avail-
able for echocardiography. Heart rate and blood pressure
were recorded every I to 2 min with a Dinamap vital signs
monitor (Critikon).
Two-dimensional erlmrardiagrophy
(Toshiba SSH-160A,
3 .75 MHz transducer) from the parasternal long-axis, short-
axis and apical four- and two-chamber views was continuous
for up to 20 min after dobutamine administration. Mitral
regurgitation was sought with Doppler color flow mapping in
the apical four-chamber view (2
.5-MHz transducer, pulse
IACC Vol. 19. No . 6
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repetition frequency 4 kHz) at baseline and every 2 min
during drug infusion. Each view was recorded on 12-mm
VHS videotape both conventionally and in slow motion
cineloop format by using the internal memory mode of the
scanner to aid wall motion analysis . The mean time between
angiographic assessment and the dobutamine study was 14 ±
10 days ; no significant cardiac events occurred during this
period
.
Treadmill exercise testing. All patients underwent a max-
imal modified Bruce treadmill exercise ECG using a comput-
erized ST segment analysis system (Case 12 . Marquette)
(20).
End points included limiting symptoms, target heart
rate (220 beats/min minus age in years), markedly elevated
systolic blood pressure or a decrease ?10 mm Hg and
significant ST segment shift or arrhythmia. Both exercise
and dobutamine stress ECGs were considered positive for
ischemia if there was ±I mm of new onset ST segment
elevation or planar or downstoping ST segment depression
80 ms after the J point in any lead on three consecutive
beats . Similarly. ±2 min of upsloping ST segment depression
was classified as a positive response
. Electrocardiograms
were interpreted by an observer unaware of the other
investigative findings . All symptoms experienced and ar-
rhythmias that developed were carefully documented, to-
gether with the reasons for exercise termination . No cardiac
events occurred between exercise testing and either coro-
nary angiography (mean interval 19 ± 10 days) or dobu-
tamine echocardiography (mean interval 7 ± 9 days) .
Cardiac catheterization . Coronary angiography utilizing
the Judkins or Sones technique and two to six projections for
each coronary artery was performed with a Philips Poly
Diagnost C imaging system . Images were recorded on
35-mm cinefllm . Coronary stenoses were evaluated qualita-
tively from end-diastolic frames by an observer unaware of
the other results
. A ?70% reduction in lumen diameter
present in at least one major epicardial vessel in each of two
orthogonal views was considered significant .
Echocardiographic image analysis. Two-dimensional
echocardiographic images were evaluated from videotape
playback in a blinded manner by two independent experi-
enced observers who adopted the same assessment criteria .
Differences in interpretation were resolved by consensus .
For wall motion analysis the left ventricle was divided into
II segments. Five segments (basal and mid-anteroseptal,
basal and mid-anterior, and apical) were assigned to the left
anterior descending coronary artery perfusion bed and six
segments (posteroseptal, inferior and lateral at basal and
mid-levels) to the right coronary and circumflex territories
combined (Fig. 1)
. Echocardiograms were read at baseline
and at each infusion dose ; segments were analyzed for
systolic wall thickening and endocardial wall motion load
were graded as hyperkinetic, normal, hypokinetic, akinetic
or dyskinetic. Results of a dobutamine echocardiogram were
considered normal if all segments that were normal at
baseline showed a normal or hyperdynamic response with
increased systolic wall thickening . The development of new
1ACC Val . IA No .
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Table 1. Clinical Data and Results of Coronary Argiography . Exercise Electrocurdioeraphy
. Dobummine Electrocardiography and
Dobolamine Echocardiography in 50 Patients
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The rime points at peak head rate (HR) and systolic blood pressure (SHP) during dobmamine infusion for each patient frequently did act coincide . Segment
numbers refer to the lee ventricular model shown in Figure I . 'The worst grade seen is stated: += present : -
= absent
a
not applicable
; CAD = customary artery
disease; ECG = electrocardiogmphy; F = female : LAD = lell anterior descending coronary artery ; LC, = left circumflex coronary artery : M = male :
Pt = patient; RCA = right coronary artery: RPP = rate-pressure product .
DObutamine Stress Echocardiography
Pt
No.
Age (yr)I
Gender
No. and
Vessels
Diseased
Haseline .Asvenrgy
EXercise
ECG
Dobutamine PeakHR
ECU Ibcats'mnll
look SOP
Imm Hp
NewlWomenine .ASynerey
+I-
Segment
No .
Pack RPP
man Hwaam +I-
Sq.-
No Na..'
Normal Subjects
I 551F None - Positive Negative ins 159
15.435
50114 Nnnc Nega:oo Negalrve 119 197 23.443
3
621F
None Positive Positive 137 197 24.523
4 41/M None - Negative Negative 133 191 '_3.541
5 401N None Negative 182
19.402
Negative
Negative lot6
57130 None
Negative 190 18 .483
7 55130 None 2 .10 Negative Po :I s, :y (75 15 .744 6.9 A 1,10,00
8 47/M None - Positive Positive 114 147 15 .696
9 28130 Nanc Negative Negative
1_'6 178 22 .428
10 60/M None - Positive Negation 115 (93 20.246
II 6VM None -- Negarivo Ibsitive 11X1 151 14
.060
12
631M
None - Negauve Negative 121 153 16.568
13 1. None Negative Neon- 149 140
19
.430
14 29/30 No . e
Negative Negative
114 177
18.270
P Bents With CAD
IS 58/F
I (LAD)
-
Positive Negative I A 199 '_9.700 11 Akinesta
Ifi 55/M
IIRCAI - NeFative Negation 96 188 16187 5.6 Dyskinese
17 69/M
IILAD I
- - Positive
Negative C9
173
18 .670 2,10.11 Hypokinesu
18 58)M I (LADI - Positive Negative 121 188 20.349 N Akinese
19 5NM I (LAD)
10
.11 Pulaive Posllivc
IC
177 17
.920
+
10,11 415100 is
20 4&30 I (RCA( - - Positive Positive 112 176 17 .776 + 5.6 Dyskinesia
21 62/M I (RCA)
- Negative
Negmive
156
174
24.939 - - -
22 58130
i(RCA) - Negative Negative 114 169 18.126 - -
23 53/M I (LAD, - Positive NeFative 126 173 20.933 - -24
58130 IILCx) -
Negative
Negmive
131
140
18.340 - -
25 601M IILADI
-
Negative Negative 99 144
N96 - -
26
681M
I (LAD) Negative Negukve 65 117 7.475 - -
27 39/M 21 LAD, LCn(
0 0
4
Positive Negative 108 145 15.660
+
10.11 Aid-
28 4AM 2 (LAD. RCA) + 2.10.11 Positive Positive t04 145 54.500 + 5.10 .11 Dyskinesa
29 59/30 2(LAD,RCA) - Positive Negative 140 164 20.860
0
95,6 Akirssia
30 6VM 2 (LAD. RCA) - Positive Positive
84 185 14.060
+
10.11 Akinesia
31 651M 2(LAD,RCA
+
1,2_ .9-II Positive Positive 93 165 15,015 + 10.11 Dyskinesia
32 42/F 2(LAD,RCAI - Positive Pasiuve 126 208 26,208 + 1 .2 .11 Akinesa
33 MM 2 (RCA, LCx) - Negative Negative t 12 164 17,696 - -
34 611M 2(RCA-LCx)
+
5 .6 Negative Negation 95 160 14,382 - -
35 53/F 2( LAD, RCA) + 10.11 Positive Positive 125 173 20,241 - -
36 60/M
2 (LAD
. RCA) 6 Positive Negative 137 173 21.646 - - -
37 59'M 3 129-11 Positive Negative 133 170 21,280 + 2.10.11 Dyskioesa
38 45130 3 - -
Positive Positive 133 150 59.551
+
4 Akinesia
39 (AIM 3
+
6 Positive Positive 134 180 21,746 4 Akinesw
40 531M 3 5 .61 Positive Positive 137 214 26.715 + 5 .6.11 Dyskieesia
41 5AM
3 - Positive Positive 121 182 22,022
+
1,2.11 Akiaesia
42 54/F 3 - Positive Positive 88 201 17 .424 4 Akisosia
43 611M 3 II Negative
Positive
IH 158 19 .257 5,6 Akinesia
44 461M 3 - Positive Negative 123 223 24,723 + 5,6 Akinesia
45 401M 3 -
Positive
Positive
100
195 17,065 4,6 Akieooia
46
47IM 3 -
Negative Negative 131 160
20
.436
+
6.8 Akinesia
47 62/30 3 Positive Positive 61 213 12.567 + 3.4 Hypokinesia
48 60/M 3 12.9-11 Positive Position 102 146 14 .746 - - -
49
611M
3
- - Positive Positive 115 146 16,080 - -
50 63)M 3
+
2.10.11 Positive Negative 1:5 (50 18 .450 - - -
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Fl-.
Prownal coo
e
RCA and LOX
Figure l . Schematic representation of the paraslernal long-axis (top
left), short-axis (papillary muscle level) (top right), apical four-
chamber (bottom left) and two-chamber (bottom right) views show,
ingthe relation of the I I-segment left ventricular model used for wall
motion analysis to coronary artery penusion . LAD = left anterior
descending coronary artery; LCX = left circumflex coronary artery :
RCA = right coronary artery
; i _ basal anteroseptal ; 2 = mid-
anteroseptal; 3 = basal lateral) 4 = mid-lateral : 5 = basal inferior :
6 = mid-inferior: 7 = basal posteroseptal : 8 = mid-posleroseptal :
9 - basal anterior; 10 = mid-anterior ; I I
-
apical .
or worsening regional asynergy, defined as hypokinesia in
any segment, before testing, deteriorating to akinesia or
dyskinesia during dobutamine stress, was considered abnor-
mal
. Evidence
of
improved wall motion in patients with
regional abnormalities at control was also sought . Mitral
regurgitation was considered present if reversed blue-green
or mosaic-colored flow signals originating from the mitral
valve were noted in the left atrium during systole on frame
by frame review.
Statistical analysis . Continuous data are expressed as
mean values t SD . Sensitivity, specificity, predictive value
and overall accuracy were calculated with standard formu-
las . Normality was determined with the Shapiro-Fmncia W'
test . Paired or two-sample r tests or corresponding nonpara-
metric statistics were performed as necessary . The chi-
square test with the Yates correction and McNemar test
were also used where appropriate . Interobserver conc,.-
dance was determined by calculating the kappa coefficient
without weighting and its 95% confidence interval ; a value
mO
.75 was considered to indicate good agreement (21). Data
analysis was performed with commercially available soft-
ware (Minitab). A p value <0.05 defined statistical signifi-
cance
.
Results
Hemodynamic response to dobutamine and exercise stress
testing (Table 1) . Figure 2 compares the hemodynamic var-
iables at each phase and dose and stage of the two tests ;
recovery to baseline tended to be more rapid after exercise ;
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Figure 2. Changes in heart rate, systolic blood pressure and rate-
pressure product during and early after dobuttunine infusion and
exercise stress in 50 patients
. Data points are mean values i SE.
however, both heart rate 182 s 16 beats/min) and rate-
pressure product (11,685 ± 2,444 mm Hg/min) approximated
values before testing l0 min after the end of dobutamine
infusion. The mean peak heart rate (140 ± 25 vs. 116 ± 20
beats/min, p < 0.001) and rate-pressure product (23,740 ±
6,158 vs . 18,845 ± 4.156 mm Hg/min, p < 0 .01) were higher
during exercise, whereas maximal systolic blood pressure
(174 ± 30 vs . 172 ± 22 mm Hg, p = NS) was similar . In
general, heart rate and systolic blood pressure increased
progressively during dobutamine infusion with no tendency
to plateau except at peak dose, although the magnitude and
time course of these changes were highly variable among
individual subjects . The mean maximal increase in heart rate
was45 ± 18 beats/min (range 71078) ; nine patients (18%) did
not attain a rate ±100 beats/min . The mean change in
diastolic blood pressure during dobutamine infusion was -6
A 15 mm Hg (p = NS vs . baseline) . There were no significant
IACC Vol
. 19 . No. 6
May 1992 :1 203-11
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Table 2 . Comparative Sensitivity . Specificity . Predictive Value and Accuracy of Dohutamine Stress Echocardiography and Dobutamine
and Exercise Electrocardiography
differences in hemodynamic response between 8 normal
subjects and 13 patients with coronary artery disease who
completed the infusion protocol .
Echocardiographic wall motion analysis (Table 2)
. Image
quality during dobutamine infusion was unchanged in all
subjects ; no patient had a significant increase in respirator y
rate. Transient hyperkinesia with enhanced systolic wall
thickening was the normal response to dobutamine infusion
and was particularly marked in the normally contracting
segments of those with regional asynergy. Fourteen patients
had asynergy at baseline, involving one segment in four
patients, two segments in four and three or more segments in
six. New (n = 19) or worsening in = 3, Patients 19, 31 and 37
in Table I) regional asynergy or both In = 2, Parents 28 and
40) was seen in 24 patients, 23 of whom had coronary artery
disease, giving a sensitivity of 64% and specificity of 93%
(Table 2) . These changes affected one, two or three segments
in 5, 13 and 6
patients, respectively with the worst segment
graded as showing dyskinesia in 6, akinesia in 16 and
hypokinesia in 2 (Table I) . When the presence of baseline or
transient regional asynergy defined a positive echocardio-
gram, sensitivity improved to 78% (28 of 36), whereas
specificity was unchanged.
The time of onset of wall motion abnormalities 117 .4 ±
6.3 min) and of diagnostic ST segment shift (18.5
it
6.5 min)
was similar in the 14 patients with coronary artery disease
who had both changes (p = 0 .1 I). Endocardiat motion had
returned to baseline in all patients at 20 min after the
infusion . A normalization in pretest regional asynergy during
dobutamine infusion was seen in three patients (Patients 31,
35 and 36) ; one subject (Patient 31) subsequently developed
dyskinesia in the involved area at a higher dose . The interval
since myocardial infarction in these patients was 5 months, 4
months and 5 years, respectively . Interobserver agreement
on waif motion expressed as the kappa
coefficient
for three
groups (normal, baseline asynergy and reversible asynergy)
was 0.77 (95% confidence interval 0 .63 to 0 .91).
Coronary angiographic correlates (Tables I and 3). All
patients with coronary artery disease with a positive echo-
eardiographic result had a significant stenosis in the vessel
supplying the abnormal segment . Six (50%) of 12 patients
with single-vessel disease had a positive study result; the
'p 10 .01
versus dobutamine electrocardiography
:
;p
=
NS versos dobutamine e
chocardiography. M R = m : ral regurgialion .
lesion was correctly localized to the left anterior descending
or right coronarylcircumflex territories in all 6 (Fig . I, Table
3). Two patients (Patients 32 and 41) with reversible involve-
ment of segment I had disease proximal to the first septal
perforator of the left anterior descending tironary artery
(Table II. and two other patients with isolated transient
apical akinesia (Patients 15 and 18) had a distal stenosis of
this vessel. Five of six patients with baseline and new
asynergy had multivessel disease; the remaining patient had
normal coronary arteries and an incoordinate left ventricular
contraction pattern before testing. Visible collateral vessels
at coronary angiography were present in 12 (52%) of 23
patients with reversible asynergy and in 8 (62%) of 13 of the
others (p = NS) .
Doppler color flow imaging . A trace (n = 12) or mild (n =
6) mitral regurgitation was present in
18
patients (36%) at
baseline, making any changes induced by dobutamine infu-
sion difficult to interpret. Five (361/0 of 14 had normal
coronary arteries and 13 (36%) of 36 had coronary artery
disease, indicating that mitral regurgitation before testing
was not diagnostically useful. New mitral regurgitation dur-
ing sinus beats developed in 4 (11%) of 36 patients with
coronary artery disease (in Patients 20, 41, 43 and 49) (Table
I) and in no patient with normal coronary arteries . The
inclusion of new mitral regurgitation in the definition of an
abnormal study result improved sensitivity to 81% without
loss of specificity (Table 2) .
Table 3. Sensitivity of Dohutamine Echocardiography (Echo) and
Dobutamine and Exercise Electrocardiography for Detection of
One-
. Two- and Three-Vessel Coronary Artery Disease
No. of
	
Dobmamien Dobuumine Exercise
Diseased Echocardiography Electrocardiography Electrocardiography
Vessels (`k) (`/0)
(%)
3
Snairivity
6/12(501 2112(17) 6/12(501
6TO(60) 5110(50) gno(60)
tuts fast 10114 470 12tw (961
A posrtivc result an a dub-mine sirens echacaediognm was defined as
the development of transient regional asynergy or new mural regurgitation .
Sen
1701 '
Sp.""",
Icii
Positron
Preddive
Value I%)
egelive
Prod
rive
val. (70
Accuracy
(1/' 1
DObuwmine echocardiography
Transient regional asynergy 8136164) 13i14 03) 23124196)
13/26(50) 36/50 (72)
Baseline or transient asynergy 2613608• 0,'14193? 2&291971 13)21 (62) 41150(x2)
Baseline or transient asyncrgy or new MR 29136 (811- 13.'14(931 29130(971 1920165)
42350(85)
Doburamine electrocardiagraphy 1776(47) 10941711
17121 (81) 10/29134) 27150154)
Exercise eledmcmdiography 1636)72/) 1014131)
2830(87) 10^-20(501 36150172)
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Dobutamine Electrocardiography (Tables I to 3). Sig-
nificant ST segment change had a sensitivity and specificity
for coronary artery disease of 47% and 71%, respectively
(Tables I and 2). Sensitivity in one-, two- and three-vessel
disease was 17%, 50% and 71% • respectively (Table 3) . The
ST segment in the 21 patients with positive ECG changes
manifested planar or downsloping depression in 17, upslop-
ing depression in 3 and elevation in I . The latter patient
(Patient 45), who had triple-vessel disease . developed ST
segment elevation in the inferior leads associated with tran-
sient akinesia of segments 4 and 6 and had a similar response
on the exercise ECG. As a rule, however. the site of ST
segment change . usually leads V s to V6 , was not .itrictly
related to the site of the wall motion abnormality
.
Exercise electrocardiography (Table 1), Sensitivity and
specificity data for the exercise ECG are given in Tattles 2
and 3 . Seventeen of 20 patients with coronary artery disease
with new asynergy and all of 5 patients with worsening
asynergy had positive findings on the exercise ECG . In
patients with coronary artery disease. exercise duration in
those with an abnormal echocardiographic response (n = 24)
was 385 ± 182 s versus 538 ± 262 s in the others In = 12)
(p < 0 .05). Similarly, time to diagnostic ST segment shift
was 273 1 178 s in patients with echocardiographic evidence
of ischemia (n = 211 compared with 475
.
212 s in those
without induction of ischemia (n = 5) (p < 0 .051. Sixteen
patients with coronary artery disease had significant ST
segment deviation during both exercise and dobutamine
stress ; the mean maximal extent of ST segment shift was 2 .1
± 9 .9 mm during exercise and 1 .8
.
0.5 mm during dobu-
tamine infusion (p- NS).
Side effects and reasons for test termination (Tables 4 and
5). All adverse reactions were mild and short-lived, resolv-
ing within 2 min after the dobutamine infusion was discon-
tinued . Table 4 shows that the overall frequency of side
effects experienced and arrhythmias induced was very sim-
ilar for the dobutamine and exercise tests . Chest pain
developed in 14 (28%) of 50 patients with dobutamine stress
compared with 23 (46%) of 50 patients during exercise (p =
0.03) . Nonsustained ventricular tachycardia (4 beats) was
seen only once and with exercise . Dobutamine induced
symptomatic hypotension in seven patients, three of whom
had associated transient functional rhythm. This effect re-
solved promptly with termination of infusion. which was
necessary in six patients, although one patient with more
prolonged hypotension needed atropine (0.6 mg) (Tables 4
and 5) . A similar vasodepressor reaction was seen in the
same patient during early recovery after exercise stress .
Discussion
The utility of exercise echocardiography in patients with
suspected or proved coronary artery disease is increasingly
appreciated (22), but it has limited application in those with
lower limb peripheral vascular, orthopedic or neurologic
disease. Alternative forms of stress, independent of ability
Dahutamine
JACC Val . 19 . No . 6
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Table 4. Side Effects and Treatment Required After Dobutamine
and Exercise Stress Testing in 50 Patients
Exercs
Total
CAD Normal Total ITI M
In = 361 (n = 14) (n = 50) In = 50)
Documentation is comprehemive and instating
trivial
reactions
.'Consid-
cred present during exercise if inordinate . CAD = coronary artery disease :
VT = ventricular tachycardia
.
or motivation to perform dynamic exercise, have therefore
been sought (22)
.
A dobutamine infusion is easily adminis-
tered, enables the generation of an incremental stress, anal-
ogous to the stages of an exercise ECG, and allows contin-
uous echocardiographic monitoring with technically easier
mage acquisition, since patients are at rest and optimally
positioned . This rationale prompted the present study,
Dobutamine induces myocardial ischemia in patients with
coronary artery disease by increasing left ventricular con-
tractility, heart rate, wall stress and, therefore, myocardial
oxygen demand beyond that which can be met by supply
(23). In accordance with the dobutamine plasma half-life and
time to peak effect, we used a regimen with dose increments
every 8 min in patients who were not receiving antianginal
medication to attain the maximal possible stress with each
dose (24) . Table 6 indicates that the mean peak heart rate and
rate-pressure product attained in our study compare favor-
ably with those documented in five previous studies of
dobutamine stress echocardiography (6-10) .
This observa-
tion lends support to the contention that both complete
washout of beta-adrenergic blocking agents and duration of
infusion are important determinants of the peak stress
achieved. Centers that do not discontiaue beta-blocker ther-
apy report using doses up to 40 yng/kg per min with additional
atropine in subjects who do not develop an adequate chro-
notropic response (6.8; Thomas Ryan, personal communica-
Side effect
Chest pain 12
2 14(28)
231461
Headache 6
4 10(20) 0
Palpitation 5
4
9118) 20)
Dizziness
4 3 7114) 1(2)
Hypetension 3 71141
U21
Dyspnea" I 500) 13 (26)
Fatigue" I 1 2(41 11 (22)
Arrhythmia
Supraventriculareclopicbeats 5 0 5(10 ; 4(8)
Supaventriculartaghycardia 1 0 1 (2) 1 (2)
Ventricular ectopic beats 10
a
12(24) t0120)
Venoicntar couplets 1 I 20) 1(2)
Nonsustained VT 0
0
0 1 (21
Junctional rhythm 4
1
5(to) 1(2)
Total
16
3 19(38) 14(28)
Grand total 31 t0 41 (821 40(80)
Treatment
Nitrates 1 0 1 (2) 1 0)
Atropine 1 0 • t2) 0
Prapana1o1 0 a 0 0
JACC Vol. 19 . No. 6
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Table S. Reasons for and Dose (stage) at Dobutamine Infusion
and Exercise Termination in 50 Patients
Some patients had more than one reason for lest termiral)oe
.'See text for
definitions.
tion, November 1990) . The Late-pressure product increased
substantially and similarly in normal subjects and in patients
with coronary artery disease but imperfectly reflects myo-
cardial oxygen demand, because the important inotropic
action of dobutamine is not represented (Fig
. 2).
Comparison with previous studies. Nonexercise-
dependent stress testing with atrial pacing combined with
transesophageal echocardiography has been reported to be
highly sensitive and specific for detection of coronary artery
disease, but the study is invasive and requires specialized
equipment that limits patient acceptance and widespread
MAZEIRA ET AL .
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application (25) . Intravenous dipyridamole combined with
two-dimensional echocardiography has been extensively
evaluated (5)
but cannot provide a progressive stepwise
stress
. Its action in inducing flow maldistribution by small-
vessel dilation probably makes it more suitable for combi-
nation with thallium perfusion imaging .
Dobutamine stress, although nonphysiologic, more
closely approximates exercise than does dipyridamole or
pacing (6-10,19) . However, it is not subject to problems of
rapid recovery of wall motion abnormalities, seen in up to
20% of patients, that limit echocardiography after treadmill
exercise (26)
or to the problems inherent in peak exercise
imaging .
A
recent report (6) found dobttamine stress echo-
cardiography to be highly sensitive (86%) and specific (95%)
for detection of coronary artery disease . These data are in
broad agreement with our own and those of Sawada et al.
(7), who studied 103 patients with doses up to 30 pg/kg per
min and obtained a sensitivity of 89% and specificity of 85%.
Previtali et at . (8) compared dipyridamole (up .o 0.84 mg leg
over 10 min) with dobutamine (up to 40 pg/kg per min)
echocardiography in 35 patients and found these tests to
have similar diagnostic accuracy, although dobutamine
echocardiography appeared to be more sensit :':e for detec-
tion of single-vessel disease.
Dobutam®e stress eehocardiag'apiy . Reversible asyn-
ergy or new mitral regurgitation was seen in 24 of 36 patients
with coronary artery disease and had a sensitivity of
50%,
60% and 86% in one-, two- and three-vessel disease, respec-
tively. The well recognized difficulties in making functional
assessments of coronary stenoses from qualitative or quan-
titative interpretation of angiograms could have led to false
negative studies in patients with angiogaphically but not
functionally significant obstructions (27). This possibility is
supported by the finding that patients with coronary artery
disease with a positive echocardiogan
. more frequently had
a positive exercise ECG (21189%] of
24 vs . 5142%] of 12,
Table 6
. Comparison of Stress Testing Regimen Used and Peak Heart Rate and Rate-Pressure Product Attained in Five Previous
Dobutamine Stress Echocardiography Studies (6-10) With Data From This Report
'Hemodynamic data at omet of new regional asyeergr . echo = two
.dlmensional echocardiogram; HR = heart rate; NA
-
not available ; R = patient ;
ref. = reference ; RPP -' rate-prossme product.
Iit Author
(ref. no.)
Patients
No. Beta-Blacker Status
Peak Dose
(pg/kgbody
weight per o is)
Duration of
Each Infusion
Rate (min)
Peak HR
(beatslmiel
peak RP?
(xLOCO
rote H e le)
Category
Cohen (6) 3-Vessel disease 17 Discontinued for 48 h
40 3 89 t 17' 12 .7 t 3.6'
Z-Vessel disease 18 Discontnued for 481
:
4
3 95 t It' 13 .7
t
28'
1-Vessel disease 16 Discontinued f 48 h
40 3 118 t IS' 18.9
t
4.4'
Sawada (7) On beta-blocker therapy 28 Not discontinued 30 3 100--29 14
t 3.9
Not on beta-blocker 75 Not on beta-bleaker 30 3 119
. 16 l6.5 t 4.2
therapy Therapy
Previtnh (8) Positive echo 19 Discontinued for 21 h
40 5 89 t 19 15.3 t 4
Negative echo 16 Discontinued for 24 h 40
5 99 ± 30 17.2 *- 5
Senhe 191 Total group 30 Not stated 40
3 113 ± 24 17.3 t NA
Mann-dng (10) Total group 38 Discontinued for 48 h
20 6-8 112 *_ 25 16.9! 4.9
Presem study Total group 50
Discontinued for 4
half-lives
20 8 116 t 20 18.8 S
42
Dobutamine
Exercise
(90) (901
Reason
Angina 30)
7114)
Fatigue
1(2)
7114)
Other symp'om
1(2) 5 )10)
Wall motion abnormality 6(12)
ST segment depression 5 )10)
15 (30)
ST segment elevation 1(2)
1(2)
Arrhytbmia 20) 3(6)
Target heart note'
908)
1000)
Hypotension' 6(12) 1 (2)
Hypertension' 1)2) 20)
End of protocol 21142) 0
Dose (stage)
5 poll per min or stage 1 0 4g)
10 pg)kg per min or stage 2 602) 13(26)
15 pg)kg per min or stage 3 12(24) 14(28)
20 pglkg per min or
stage 4
32(64) 9(18)
siege 5
704)
stage 6
316)
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p < 0 .05) and also a significantly shorter exercise duration
and time to diagnostic ST segment deviation than did those
with a negative study. Our high specificity (93%) is probably
an overestimate because of the exclusion of subjects with
nonatherosclerotic cardiac disorders
.
Transient regional asynergy was seen in three of four
patients with coronary artery disease with new mitral regur-
gitation, suggesting that this phenomenon has an ischemic
basis and may represent a useful additional marker for
coronary artery disease (28,29) . However, an important
limitation was the presence of mitral regurgitation at baseline
in 18 patients (36%). Because mitral regurgitation was seen
with equal frequency in our normal subjects and patients
with coronary artery disease, it did not aid diagnosis . The
other common problem complicating interpretation of color
flow signals was artifact generated during dobutamine stress
by the encoding of hyperdynamic cardiac structures that
appeared as transient sheets or flashes of color . Optimal filter
settings minimize confusion, although frame by frame review
generally enables the differentiation of regurgitant jets (28) .
Wall motion analysis . Worsening regional asynergy was
seen in five patients
. Although this response is compatible
with ischemia of remaining viable myocardium in an infarct
zone, the change in regional loading induced by dobulamine
infusion is a possible alternative explanation . Both mecha-
nisms may contribute to varying degrees in individual pa-
tients . Conversely, improved wall motion with dobutamine
infusion was noted in three patients . This surprise finding
may represent stunned myocardium (perhaps caused by an
episode of asymptomatic or unreported ischemia shortly
before the test) or myocardial hibernation, since inetropic
stimulation improves function in both of these altered myo-
cardial states (30,31) . Traction from neighboring segments is
a less likely explanation because of the circumferential
extent of the baseline abnormality (32) .
The site of reversible asynergv successfully localized a
stenosis to the left anterior descending or right coronary/left
circumflex territories in all 6 of the 12 patients with single-
vessel disease who had a positive echocardiogram . Basal
anteroseptal involvement correctly predicted a proximal left
anterior descending coronary artery lesion, whereas isolated
apical asynergy predicted distal disease.
Wall motion may be analyzed from videotape or after
digital image capture in a cineloop format
; unfortunately,
these two methods have not been formally compared
(22).
Digital acquisition systems enable side by side comparison
of baseline and peak stress images but only evaluate early
systole, which ignores potentially important endocardial mo-
tion during the rest of the cardiac cycle (33) . A combination of
digital and videotape image analysis may therefore be optimal .
Quantitative analysis of regional function was not per-
formed in this study because of the known confounding
effects of cardiac translation and rotation
. The qualitative
approach adopted by us and other workers (6-10) resulted in
good interobserver agreement . Freeman et al . (18) observed
an abnormal ejection fraction response on dobutamine radio-
1ACC Vol. 19. No, 6
May 1992 :1203-11
nuclide ventriculography in only 28% of patients with coro-
nary artery disease who had new regional asynergy and in no
patient without this, suggesting that measurement of globs ;
indexes of left ventricular function during dobutamine stress
is noncontributory . These disappointing results have been
confirmed by other workers (34) and may reflect exaggerated
hyperkinesia of normal segments in patients with regional
wall motion abnormalities.
Safety of dobutamine stress. In agreement with other
studies (6-10), we found dobutamine infusion to be safe and
well tolerated. Side effects were all mild and transient, and
no patient needed intravenous beta-blocker reversal . Ar-
rhythmias,seen with similar frequency on exercise, tended
to occur during rather than after drug administration and
prompted test termination only twice ; one patient had ven-
tricular couplets, and the other had frequent ventricular
premature beats . Pooling our data with those of five previous
reports (6-10) revealed that nonsustained ventricular tachy-
cardia (three or more ventricular premature complexes) was
induced in 9 (2 .6%) of 342 tests and that this was hemody-
nautically insignificant in every case . The occurrence of
hypote .^iion associated with heart rate deceleration and
dizziness in seven patients (14%) may be due to the trigger-
ing of a cardiovascular vasodepressor reflex by dobutamine
infusion (35) . This reaction led to infusion termination in six
instances and probably represents a limitation of dobutamine
stress testing.
Clinical impuwiiO,ts . Our results demonstrate the utility
of dobutamine stress echocardiography in the evaluation of
patients with coronary artery disease and further extend the
application of cardiac ultrasound in the assessment of this
condition . Because this test involves no radiation exposure,
is quicker and cheaper and, in general, more readily acces-
sible than rival nuclear imaging techniques, it should find
wide application
. The recent technical advances in image
acquisition and display may further improve diagnostic
accuracy by aiding identification of relatively subtle and
localized transient regional asynergy . Future studies should
also determine whether atropine coadministration improves
test sensitivity without compromising safety or patient ac-
ceptability .
We thank Senka Dinarevic . Mohammed Khan end to Joshi for expert
technical assistance .
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